Rapid Vaccine Development Technology
Goal:
Secure funds for rapid vaccine development technology.
Results:
$10M was appropriated to rapid vaccine development in the Department of Defense appropriations bill — $6M was award to client for a project with the Department of Defense
Held two congressional briefings on vaccines featuring public health experts and doctors to educate on vaccines and the technology
Established relationships with Department of Defense, Medical Technology Enterprise Consortium (MTEC), National Institutes of Health (NIH), National Cancer Institute (NCI), and National Institute of Allergy and Infectious Diseases (NIAID) leading to collaboration and funding opportunities
Held more than 50 meetings with Congressional Offices
Invited to present posters two years in a row at Military Health Research Systems Symposium (MHSRS)